文献速递创伤骨科关节外科脊柱外科

术后停用阿片类药物评分在种族和社会经济亚组中的表现如何

Does the Stopping Opioids After Surgery Score Perform Well Among Racial and Socioeconomic Subgroups?
PubMed 文献 · Clin Orthop Relat Res · 2023-05-09

本研究基于美国东北部大型城市学术健康系统2018年1月1日至2022年3月31日接受8种骨科手术的26,114例成人患者数据,回顾性评估术后停用阿片类药物(SOS)评分在种族、民族和社会经济亚组中的区分能力。结果显示,SOS评分在非西班牙裔白人患者中c统计量为0.79,在西班牙裔患者中为0.66(p<0.001)且倾向于高估持续阿片类药物使用风险,在非西班牙裔亚裔和非西班牙裔黑人患者中未显示更差,不同社会经济地位组间无差异。作者结论认为SOS评分在西班牙裔患者中表现不佳,不应在该人群中使用。

要点

  • SOS评分在非西班牙裔白人患者中c统计量为0.79,与既往研究范围一致。
  • 西班牙裔患者c统计量为0.66(95%CI 0.52-0.79;p<0.001),评分倾向于高估持续阿片类药物使用风险。
  • 不同社会经济地位组间评分表现无差异(贫困组0.79 vs 非贫困组0.78;p=0.92)。

核心结论

  • SOS评分在非西班牙裔白人患者中表现充分,但在西班牙裔患者中表现更差,其95%CI几乎包含曲线下面积0.5,提示该工具对西班牙裔患者预测持续阿片类药物使用并不优于随机机会。
  • 在西班牙裔人群中,SOS评分常高估阿片类药物依赖风险;其表现在不同社会人口学背景患者间无差异。
  • 未来研究可能旨在阐明为何SOS评分高估西班牙裔患者的预期阿片类药物处方,以及该工具在更具体西班牙裔亚组中的效用。

研究设计与样本

  • 回顾性研究,使用美国东北部大型城市学术健康系统内部纵向维护的登记数据。
  • 纳入2018年1月1日至2022年3月31日期间接受肩袖修复、腰椎间盘切除、腰椎融合、全膝关节置换、全髋关节置换、踝关节或桡骨远端切开复位内固定或前交叉韧带重建的26,732例成人患者。
  • 排除因住院时间信息缺失的274例(1%)、出院信息缺失的15例(0.06%)、因失访导致药物信息缺失的310例(1%)以及住院期间死亡的19例(0.07%),最终26,114例成人患者纳入分析。
  • 队列中位年龄63岁(IQR 52-71),女性占52%(13,462/26,114);自我报告种族和民族为非西班牙裔白人占78%(20,408/26,114),非西班牙裔黑人占4%(939)、非西班牙裔亚裔占2%(638)、西班牙裔占1%(365);低社会经济地位(定义为有Medicaid保险)占5%(1,295)。

主要发现

  • 非西班牙裔白人患者c统计量为0.79(95%CI 0.78-0.81),落在既往研究范围内。
  • 西班牙裔患者c统计量为0.66(95%CI 0.52-0.79;p<0.001),评分倾向于高估持续阿片类药物使用风险。
  • 非西班牙裔亚裔患者c统计量为0.79(95%CI 0.67-0.90;p=0.65),未显示比白人患者表现更差。
  • 非西班牙裔黑人患者c统计量为0.75(95%CI 0.69-0.81;p=0.003),重叠的置信区间提示SOS评分在该人群中未表现更差。
  • 社会经济地位组间评分表现无差异:社会经济弱势患者c统计量为0.79(95%CI 0.74-0.83),非社会经济弱势患者为0.78(95%CI 0.77-0.80);p=0.92。

关键数值与推荐

  • SOS评分区分能力用c统计量衡量,取值0至1,0.5代表不优于随机机会,小于0.7通常被认为较差;既往研究中SOS评分的基线表现范围为0.76至0.80。
  • 低社会经济地位定义为有Medicaid保险,依据既往SOS评分研究。

临床怎么用

  • 作者认为,基于该分析,SOS评分不应在西班牙裔患者中使用。
  • 作者指出,SOS评分是抗击阿片类药物流行持续努力中的有价值工具,但其临床适用性存在差异。
  • 作者提供了一个框架,说明其他预测模型在实施前应如何在各种代表性不足的人群中接受测试。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Stopping Opioids After Surgery (SOS) score is a validated tool that was developed to determine the risk of sustained opioid use after surgical interventions, including orthopaedic procedures. Despite prior investigations validating the SOS score in diverse contexts, its performance across racial, ethnic, and socioeconomic subgroups has not been assessed. QUESTIONS/PURPOSES: In a large, urban, academic health network, did the performance of the SOS score differ depending on (1) race and ethnicity or (2) socioeconomic status? METHODS: This retrospective investigation was conducted using data from an internal, longitudinally maintained registry of a large, urban, academic health system in the Northeastern United States. Between January 1, 2018, and March 31, 2022, we treated 26,732 adult patients via rotator cuff repair, lumbar discectomy, lumbar fusion, TKA, THA, ankle or distal radius open reduction and internal fixation, or ACL reconstruction. We excluded 1% of patients (274 of 26,732) because of missing length of stay information, 0.06% (15) for missing discharge information, 1% (310) for missing medication information related to loss to follow-up, and 0.07% (19) who died during their hospital stay. Based on these inclusion and exclusion criteria, 26,114 adult patients were left for analysis. The median age in our cohort was 63 years (IQR 52 to 71), and most patients were women (52% [13,462 of 26,114]). Most patients self-reported their race and ethnicity as non-Hispanic White (78% [20,408 of 26,114]), but the cohort also included non-Hispanic Black (4% [939]), non-Hispanic Asian (2% [638]), and Hispanic (1% [365]) patients. Five percent (1295) of patients were of low socioeconomic status, defined by prior SOS score investigations as patients with Medicaid insurance. Components of the SOS score and the observed frequency of sustained postoperative opioid prescriptions were abstracted. The performance of the SOS score was compared across racial, ethnic, and socioeconomic subgroups using the c-statistic, which measures the capacity of the model to differentiate between patients with and without sustained opioid use. This measure should be interpreted on a scale between 0 and 1, where 0 represents a model that perfectly predicts the wrong classification, 0.5 represents performance no better than chance, and 1.0 represents perfect discrimination. Scores less than 0.7 are generally considered poor. The baseline performance of the SOS score in past investigations has ranged from 0.76 to 0.80. RESULTS: The c-statistic for non-Hispanic White patients was 0.79 (95% CI 0.78 to 0.81), which fell within the range of past investigations. The SOS score performed worse for Hispanic patients (c-statistic 0.66 [95% CI 0.52 to 0.79]; p < 0.001), where it tended to overestimate patients' risks of sustained opioid use. The SOS score for non-Hispanic Asian patients did not perform worse than in the White patient population (c-statistic 0.79 [95% CI 0.67 to 0.90]; p = 0.65). Similarly, the degree of overlapping CIs suggests that the SOS score did not perform worse in the non-Hispanic Black population (c-statistic 0.75 [95% CI 0.69 to 0.81]; p = 0.003). There was no difference in score performance among socioeconomic groups (c-statistic 0.79 [95% CI 0.74 to 0.83] for socioeconomically disadvantaged patients; 0.78 [95% CI 0.77 to 0.80] for patients who were not socioeconomically disadvantaged; p = 0.92). CONCLUSION: The SOS score performed adequately for non-Hispanic White patients but performed worse for Hispanic patients, where the 95% CI nearly included an area under the curve value of 0.5, suggesting that the tool is no better than chance at predicting sustained opioid use for Hispanic patients. In the Hispanic population, it commonly overestimated the risk of opioid dependence. Its performance did not differ among patients of different sociodemographic backgrounds. Future studies might seek to contextualize why the SOS score overestimates expected opioid prescriptions for Hispanic patients and how the utility performs among more specific Hispanic subgroups. CLINICAL RELEVANCE: The SOS score is a valuable tool in ongoing efforts to combat the opioid epidemic; however, disparities exist in terms of its clinical applicability. Based on this analysis, the SOS score should not be used for Hispanic patients. Additionally, we provide a framework for how other predictive models should be tested in various lesser-represented populations before implementation.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Crawford AM, Striano BM, Gong J, et al. Does the Stopping Opioids After Surgery Score Perform Well Among Racial and Socioeconomic Subgroups? Clin Orthop Relat Res. 2023. PMID: 37159263. doi:10.1097/CORR.0000000000002697

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。